Literature DB >> 8423195

Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol.

M W Beckmann1, A Scharl, B J Rosinsky, J A Holt.   

Abstract

Strategies for diagnosis and therapy in which sex steroid receptor ligands serve as carriers for radionuclides are attractive because a high incidence of carcinomas of the female genital tract and the breast that are seen clinically have an abundant expression of one or more of the receptor proteins. A radiohalogenated estrogen receptor (ER) ligand, 16 alpha-[123I]iodo-17 beta-estradiol [123I]E, has met clinical criteria for receptor-mediated diagnostic imaging. Its [125]I-labeled sister nuclide derivative [125I]E decays by orbital electron capture with emission of very-low-energy (Auger) electrons, which gives this latter radiohalogen the potential to serve in pharmaceuticals for radiotherapy; as examples, [125I]deoxyuridine, when incorporated into the DNA molecule, or [125I]E, when bound to the receptor within ER-rich tumor cells, are both cytotoxic in vitro. Whereas the mechanisms and subcellular changes that accompany the cytotoxicity from [125I]deoxyuridine are well documented in the form of aberrations and breaks in the cellular DNA, the effects at the subcellular level causing the cytotoxicity of the sex steroid receptor ligand [125I]E have not been characterized and are the focus of our study. We found that in a standard colony-forming assay the addition of [125I]E to the cultures decreased the survival rate of ER-positive MCF-7 cells in a dose-dependent manner. The decreased survival rate was prevented by the addition of competing excess radioinert ER ligand (diethylstilbestrol); [125I]E did not reduce survival in ER-negative MCF-7 cells. The [125I]E-induced and ER-mediated cytotoxicity was accompanied by aberrations in the DNA components of the nuclei of the cells. These included chromatid and chromosome breaks, gaps, and tri-radial chromosome formation. Our findings add plausibility and credence to the notion that the cytotoxicity imparted by Auger-electron-emitting radioligands for sex steroid receptors is in part attributable to radiodecay that causes double-stranded breakage of DNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423195     DOI: 10.1007/bf01624432

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  Scintillation proximity assay: determination of steroid hormones without separation of antibody-bound and free ligand.

Authors:  L M Swinkels; H A Ross; T J Benraad
Journal:  Ann Clin Biochem       Date:  1991-01       Impact factor: 2.057

2.  The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA.

Authors:  E W Bradley; P C Chan; S J Adelstein
Journal:  Radiat Res       Date:  1975-12       Impact factor: 2.841

Review 3.  Radiobiologic implications of the microscopic distribution of energy from radionuclides.

Authors:  S J Adelstein; A I Kassis
Journal:  Int J Rad Appl Instrum B       Date:  1987

4.  Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells.

Authors:  A I Kassis; S J Adelstein; C Haydock; K S Sastry; K D McElvany; M J Welch
Journal:  Radiat Res       Date:  1982-05       Impact factor: 2.841

5.  Range of radiochemical damage to DNA with decay of iodine-125.

Authors:  R F Martin; W A Haseltine
Journal:  Science       Date:  1981-08-21       Impact factor: 47.728

6.  Binding of radiolabeled estrogens by human cells in vitro: implications to the development of a new diagnostic and therapeutic modality in the treatment of malignancies with estrogen receptors.

Authors:  R E Anderson; J A Holt
Journal:  Gynecol Oncol       Date:  1989-07       Impact factor: 5.482

7.  Selective chromosomal damage and cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human cancer cells.

Authors:  D V Woo; D Li; J A Mattis; Z Steplewski
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

8.  Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red.

Authors:  R D Bindal; K E Carlson; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Steroid Biochem       Date:  1988-09       Impact factor: 4.292

9.  [Tumor scintigraphy using 123I-labeled estradiol in breast cancer--receptor scintigraphy].

Authors:  K Scheidhauer; S Müller; K Smolarz; P Bräutigam; B Briele
Journal:  Nuklearmedizin       Date:  1991-06       Impact factor: 1.379

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  2 in total

1.  Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.

Authors:  Dong Zhou; Terry L Sharp; Nicole M Fettig; Hsiaoju Lee; Jason S Lewis; John A Katzenellenbogen; Michael J Welch
Journal:  Nucl Med Biol       Date:  2008-06-30       Impact factor: 2.408

Review 2.  Auger electrons for cancer therapy - a review.

Authors:  Anthony Ku; Valerie J Facca; Zhongli Cai; Raymond M Reilly
Journal:  EJNMMI Radiopharm Chem       Date:  2019-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.